iSpecimen Inc.

US$0.81As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ISPCHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (80.89%)
Div yield —
ROE (968.47%)
Diagnostics & Research
Beta (5Y) 1.78
PE TTM —
TSR TTM (97.39%)
Mkt cap US$2.051M
ROIC (407.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.966
18.69%
(28.86%)
Hold 6|7|5|8|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
10.61%
12.33%
21.10%
12.12%
Revenue$M
0.103
0.106
0.107
0.114
4.50%
8.17%
7.01%
8.49%
Peers (US$2.051M)
Cap (US$)
PE
5.055M
—
Capital
TTM
5Y
10Y
Leveragex
0.235
—
—
EBIT/Intx
0.052
0.750
0.860
Own earn%
38.33
41.21
63.95
Sh yield%
50.55
39.61
36.16
Owners
Insiders/Inst%
2.01
31.90
Short interest%
3.42
SBC / revenue%
4.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
27–36
$1 testx
0.1
Incr. ROIC%
30